Invention Grant
- Patent Title: Collagen peptide, dipeptide and malady inhibitor
- Patent Title (中): 胶原肽，二肽和恶性抑制剂
-
Application No.: US13523438Application Date: 2012-06-14
-
Publication No.: US08410062B2Publication Date: 2013-04-02
- Inventor: Fumihito Sugihara , Naoki Inoue , Seiko Koizumi , Chinfang Liu , Hajime Takasaki , Hisayuki Kobayashi , Hiroshi Mano , Sachie Nakatani , Masahiro Wada
- Applicant: Fumihito Sugihara , Naoki Inoue , Seiko Koizumi , Chinfang Liu , Hajime Takasaki , Hisayuki Kobayashi , Hiroshi Mano , Sachie Nakatani , Masahiro Wada
- Applicant Address: JP Osaka
- Assignee: Nitta Gelatin Inc.
- Current Assignee: Nitta Gelatin Inc.
- Current Assignee Address: JP Osaka
- Agency: Roylance, Abrams, Berdo & Goodman, L.L.P.
- Priority: JP2008-254552 20080930
- Main IPC: A61K38/05
- IPC: A61K38/05
Abstract:
A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.
Public/Granted literature
- US20120258919A1 Collagen peptide, dipeptide and malady inhibitor Public/Granted day:2012-10-11
Information query
IPC分类:
